Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

There are only 3 ways to allocate health care resources

David L. Katz, MD
Policy
July 8, 2015
461 Shares
Share
Tweet
Share

shutterstock_207548383

Manny Alvarez is a 23-year-old college student with the misfortune of having not just a devastating cancer — but the wrong devastating cancer. The chemotherapeutic agents shown to be highly active against his specific tumor cells are FDA approved for the treatment of leukemia, but not for the stunningly rare kind of sarcoma with which Manny has been diagnosed. Nothing is FDA approved, or standard care, for the stunningly-rare cancer with which Manny has been diagnosed.

That potentially effective drugs have been identified at all is thanks to Manny’s exemplary oncologist, Dr. Breelyn Wilky at the University of Miami Health Center. Dr. Wilky sent specimens from Manny’s tumor, resected from his leg and requiring partial reconstruction of his femur and knee, to be tested in a lab against some 200 potential medications. Dr. Wilky did this because Manny had no other options; as noted, there is no established treatment for his cancer, and the drug he had received in a clinical trial at the NIH was entirely ineffective. Dr. Wilky is the kind of doctor we all hope to have in a really tough situation; the kind that doesn’t stop until she finds a way to help.

She found a way. The particular leukemia drugs she tested were completely effective against Manny’s tumor in the lab, killing off all the rogue cells. That does not guarantee the same results in the complex system of Manny’s body, but it is more than a sound basis to justify their use.

Unfortunately, Manny’s insurance company, Blue Cross Blue Shield of Florida, has chosen to see it differently. The drugs in question are very expensive, with costs of treatment running to some $300,000. Since they are not established as standard therapy for Manny’s particular cancer, the insurer has declined to cover those costs.

Does that make Blue Cross Blue Shield of Florida the bad guy in this scenario? Both yes, and no.

Yes, because it’s perfectly clear what needs to happen here. No family, no doctor, no decent person could sanction denying potentially life-saving treatment to this 23-year-old who should have his whole life ahead of him. There is reason to believe effective treatment has been identified; there is a moral obligation to administer it. That in turn means the bill needs to be paid, if not by the insurer, then by the family. If there are actual human beings at the insurance company under the veneer of dispassionate bureaucracy, they must be aware of that. They must know that they have, in effect, said to the family: deal with your son’s devastating cancer, and at the same time, find a way to raise $300,000 and/or go bankrupt. Whether or not that makes them the “bad guy,” I think we can agree it’s a long way from customary “good guy” behavior.

But there is a defense of BCBS of Florida in that the problem is bigger than them. They clearly can’t cover every therapy requested in a desperate situation, many of which might be misguided and futile. In the absence of a national standard and clear criteria for differentiating valid from invalid requests, their fall back position is the same as every other insurer: cite chapter and verse of the company rule book.

But I don’t think that satisfies. We should have, and could certainly establish, a national standard for denying insurers the right to deny coverage of care. Manny’s case would certainly satisfy any reasonable criteria. For instance, we might say that insurers are obligated to cover non-standard treatment if, and only if: 1) there is no standard treatment being overlooked or untried; 2) there is a desperate need for treatment, as affirmed by a qualified physician; 3) there is a specific treatment being recommended by a qualified physician; and 4) there is evidence to support the potential efficacy of the treatment. If the bar is set anywhere in this neighborhood, Manny’s case clears it readily.

When I expressed some of these same sentiments previously in my columns, one of the many, mostly very supportive comments received included this:

The insurance company is not a bottomless well and chooses to help as many people as they can with the highest probable success outcome. If they cover three kidney transplants instead of this one case, saving three lives, but not helping one, is that the right call?

This argument could have validity if any such either/or decisions were actually made. But with the exception of an abandoned health care rationing experiment in Oregon, they are not. If a treatment is considered standard, it is covered — no matter how many other lives might be saved with a reallocation of those same resources. Consider, for instance, how much of the total health care expenditure in our country is directed to the end of life. Much of this care is for what we might call “heroic” measures, but misguided might be a better word. The recipients are often very old, and extremely sick — with little to no prospect of getting back to a decent quality of life. Hundreds of thousands of dollars are spent routinely on nearly futile efforts in such scenarios. So, the rebuttal to my commenter is: How many Mannys might we save if we avoided futile care with no hope of restoring anything resembling health, and little hope of doing more than postponing death by some scant number of miserable days?

The reality is that we have not even grappled with the question. What is routinely covered is covered, what isn’t is not — and if that results not only in rationing, but totally irrational rationing — we all seem to be OK with it. Until the patient needing some treatment not situated in this silly scenario is our son, or our daughter. Then it’s not OK, which really means — it never was.

We need to help Manny, and can — by helping to change the insurer’s mind and by lending what direct support we all can to his family. He is in the expert and caring hands of Dr. Wilky, and getting the treatment he desperately needs as we speak. Let’s do our part to make sure that doesn’t bankrupt his family.

But we need to change the prevailing standards, too, because there will be another Manny, another family, and another insurer — and if the same rules apply, if will feel a lot like déjà vu, all over again. Some other family will be the victim. We need a national standard, not bureaucratic and profit-driven knee jerks, to guide coverage of non-standard care. I will be working on that, and seeking the help of my friends in Congress.

We also need to consider that we have just three options for the allocation of health care resources. We can choose not to ration at all, in which case the lone argument against coverage of Manny’s care is undone. We can choose to ration rationally, in which case Manny’s care would be a priority on almost any scale imaginable. Or we can ration irrationally, and deny care when it is medically indefensible and morally repugnant to do so, even as we spend extravagantly on misguided futility. Alas, until we address it, that last, bad option — is the status quo.

David L. Katz is founding director, Yale-Griffin Prevention Research Center. He is the author of Disease-Proof: The Remarkable Truth About What Makes Us Well.

Image credit: Shutterstock.com

Prev

The ability to diagnose cancer is a necessary evil

July 8, 2015 Kevin 1
…
Next

This is the best way to treat chronic insomnia

July 9, 2015 Kevin 6
…

Tagged as: Public Health & Policy

Post navigation

< Previous Post
The ability to diagnose cancer is a necessary evil
Next Post >
This is the best way to treat chronic insomnia

More by David L. Katz, MD

  • Dr. Oz: I have met the enemy. It is us.

    David L. Katz, MD
  • a desk with keyboard and ipad with the kevinmd logo

    The dietary guidelines are for which Americans, exactly?

    David L. Katz, MD
  • a desk with keyboard and ipad with the kevinmd logo

    No, it’s not the broccoli: What to make of the new dietary guidelines

    David L. Katz, MD

More in Policy

  • Why the WHO’s pandemic accord is critical for global health care

    Elizabeth Métraux
  • The revolutionary Kaiser-Geisinger deal: How health care giants are reshaping the industry and empowering patients

    Robert Pearl, MD
  • Unveiling the intricate link between housing costs and health care

    Harvey Castro, MD, MBA
  • Uncovering the truth about racial health inequities in America: a book review

    John Paul Mikhaiel, MD
  • Why affirmative action is crucial for health equity and social justice in medicine

    Katrina Gipson, MD, MPH
  • The untold story of Hispanic/Latino health: Why subgroup data matters

    Matthew B. Alonso
  • Most Popular

  • Past Week

    • Physician entrepreneurs offer hope for burned out doctors

      Cindy Rubin, MD | Physician
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • We need a new Hippocratic Oath that puts patient autonomy first

      Jeffrey A. Singer, MD | Physician
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
  • Recent Posts

    • Proposed USPSTF guideline update: Advocating for earlier breast cancer screening at age 40

      Hoag Memorial Hospital Presbyterian | Conditions
    • The rising threat of lung cancer in Asian American female nonsmokers

      Alice S. Y. Lee, MD | Conditions
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • Healing trauma and reconnecting: Unmasking the impact of dissociation [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why the WHO’s pandemic accord is critical for global health care

      Elizabeth Métraux | Policy
    • The revolutionary Kaiser-Geisinger deal: How health care giants are reshaping the industry and empowering patients

      Robert Pearl, MD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 13 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • When You Know Better, Do Better for People With Disabilities
  • Could Semaglutide Help Curb Addictive Behaviors?
  • 'If the Narcan Isn't Working, Give More' and Other Myths About Naloxone Use
  • CDC: Children's Brain Infections Rose Last Winter, But Remained Rare
  • Inside the Fight Against Burnout Amid the Chaos of War in Ukraine

Meeting Coverage

  • Cardiovascular Risk Models Still Fall Short for Arthritis Patients
  • De-Escalated Surgery Suffices for Low-Risk Cervical Cancer
  • More Evidence Backs Gout Benefit for Gliflozin Agents
  • Reaction to FDA's Approval of Upadacitinib for Crohn's Disease
  • CDK4/6 Extends Reach Into Early-Stage Breast Cancer
  • Most Popular

  • Past Week

    • Physician entrepreneurs offer hope for burned out doctors

      Cindy Rubin, MD | Physician
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • We need a new Hippocratic Oath that puts patient autonomy first

      Jeffrey A. Singer, MD | Physician
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
  • Recent Posts

    • Proposed USPSTF guideline update: Advocating for earlier breast cancer screening at age 40

      Hoag Memorial Hospital Presbyterian | Conditions
    • The rising threat of lung cancer in Asian American female nonsmokers

      Alice S. Y. Lee, MD | Conditions
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • Healing trauma and reconnecting: Unmasking the impact of dissociation [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why the WHO’s pandemic accord is critical for global health care

      Elizabeth Métraux | Policy
    • The revolutionary Kaiser-Geisinger deal: How health care giants are reshaping the industry and empowering patients

      Robert Pearl, MD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

There are only 3 ways to allocate health care resources
13 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...